Inventor

Allen B. Reitz

Inventor

Lansdale, PA, US

Overview

1988–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 79 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds37%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%

A61KPreparations for medical, dental or toiletry purposes17%

C07CAcyclic or carbocyclic compounds5%

A61QSpecific use of cosmetics or similar toiletry preparations3%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%

C07HSugars3%

C07KPeptides2%

A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation1%

Y02ATechnologies for adaptation to climate change1%

PatentTitleYear

11,052,070Riluzole prodrugs and their use2021 10,844,026Prodrugs of riluzole and their method of use2020 10,780,084Antibody-recruiting molecules for the treatment of cancer2020 10,639,298Prodrugs of riluzole and their method of use2020 10,562,870Prodrugs of riluzole and their method of use2020 10,485,791Riluzole prodrugs and their use2019 10,442,763EBNA1 inhibitors and methods using same2019 10,421,718EBNA1 inhibitors and their method of use2019 10,357,497Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis2019 10,329,269Indene derivatives and uses thereof2019 10,160,756Antiviral compounds and methods using same2018 10,112,895Antivirals against molluscum contagiosum virus2018 9,856,214'EBNA1 inhibitors and their method of use'2018 9,725,427'Prodrugs of riluzole and their method of use'2017 8,937,096'Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder'2015 8,853,263'Co-therapy for the treatment of epilepsy and related disorders'2014 8,778,956'Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders'2014 8,716,231'Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain'2014 8,691,867'Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction'2014 8,633,322'Alkynyl derivatives useful as DPP-1 inhibitors'2014 8,609,849'Hydroxylated sulfamides exhibiting neuroprotective action and their method of use'2013 8,530,475'Bridged aryl piperazines derivatives useful for the treatment of CNS, GI-urinary and reproductive disorders'2013 8,501,791'1,2,4-thiadiazolium derivatives as melanocortin receptor modulators'2013 8,497,298'Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels'2013 8,492,431'Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity'2013 8,426,429'2-amino-quinazoline derivatives useful as inhibitors of Î²-secretase (BACE)'2013 8,383,637'2-amino-quinazoline derivatives useful as inhibitors of Î²-secretase (BACE)'2013 8,084,490'Sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders'2011 8,076,358'6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of Î²-secretase (BACE)'2011 7,932,261'Macrocycle derivatives useful as inhibitors of Î²-secretase (BACE)'2011 7,868,022'2-amino-quinoline derivatives useful as inhibitors of Î²-secretase (BACE)'2011 7,786,311'1,2,4-thiadiazolium derivatives as melanocortin receptor modulators'2010 7,786,116'2-amino-quinoline derivatives useful as inhibitors of Î²-secretase (BACE)'2010 7,776,882'2-amino-3,4-dihydro-quinoline derivatives useful as inhibitors of Î²-secretase (BACE)'2010 7,582,649'Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders'2009 7,576,105'Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives'2009 7,560,459'Substituted sulfamate anticonvulsant derivatives'2009 7,531,545'2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of Î²-secretase (BACE)'2009 7,375,123'1,2,4-thiadiazole derivatives as melanocortin receptor modulators'2008 7,319,107'1,2,4-thiadiazolium derivatives as melanocortin receptor modulators'2008 7,179,818'Substituted aminoquinuclidine compounds'2007 7,081,463'Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders'2006 7,060,725'Substituted sulfamate anticonvulsant derivatives'2006 7,053,101'1,3,8-triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders'2006 7,049,331'1,2,4-thiadiazole derivatives as melanocortin receptor modulators'2006 7,018,797'Method for treating neurodegenerative disorders'2006 6,890,921'Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia'2005 6,887,876'Benzamidine derivatives'2005 6,809,107'Neurotrophic pyrrolidines and piperidines, and related compositions and methods'2004 6,777,421'1,3,8-Triazaspiro4.5decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders'2004 6,593,474'Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia'2003 6,531,478'Amino pyrazole derivatives useful for the treatment of obesity and other disorders'2003 6,511,998'Pyrazole carboxamides useful for the treatment of obesity and other disorders'2003 6,465,486'Pyridyl/quinolinyl imidazoles'2002 6,441,049'Method of treating neurodegenerative disorders via inhibition of amyloid beta peptide binding'2002 6,436,959'4-aryl(piperidin-4-yl)aminobenzamides'2002 6,407,136'1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor'2002 6,358,946'C-6 ring-substituted pyrido1,2-abenzimidazole derivatives useful in treating central nervous system disorders'2002 6,313,309'4-thionaphthyl--1H--imidazoles which are useful.alpha.22-adrenoceptoR agonists/ antagonists'2001 6,291,476'Pyrazole carboxamides useful for the treatment of obesity and other disorders'2001 6,200,984'Naphtho-imidazo pyridine derivatives useful in treating central nervous system disorders'2001 6,140,354'N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders'2000 6,071,915'Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia'2000 5,968,946'Heterocyclic derivatives useful in treating central nervous system disorders'1999 5,922,731'5-›(heteroaryl)alkyl!-3-oxo-pyrido›1,2-a!benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders'1999 5,817,668'S-heteroatom containing alkyl substituted-3-oxo-pyrido›1,2-A!benzimidozole-4-carboxamide derivatives useful in treating central nervous system disorders'1998 5,786,359'N.sup.9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines'1998 5,569,659'4-arylpiperazines and 4-arylpiperidines'1996 5,512,566'Tricyclic compounds having affinity for the 5-HT1A receptor'1996 5,449,677'Cyclic benzylamino, benzylamido and benzylimido antipsychotic agents'1995 5,441,942'2\'3\'-dideoxy-2\',3\'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect'1995 5,439,907'Use of N9 morpholino derivatives of 7,8-disubstituted guanines'1995 5,382,580'N9 morpholino derivatives of 7,8-disubstituted guanines'1995 5,332,743'Benzyl and benzhydryl alcohols'1994 5,332,732'Thiophene and pyridine antipsychotic agents'1994 5,332,738'Imidazolidine antipsychotic agents'1994 5,314,885'Cyclic benzylamino, benzylamido, and benzylimido antipsychotic agents'1994 5,290,948'Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof'1994 4,745,185'D-arabinose-1,5-diphosphate salts and methods for the treatment of diabetes'1988

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1988–1996Patents assigned to MCNEILAB INC (7)· patent assignee history

1988Based in North Wales, PA, US· patent location history

1994–2021Based in Lansdale, PA, US· patent location history

1999–2010Patents assigned to ORTHO MCNEIL PHARM INC (21)· patent assignee history

2006–2015Patents assigned to JANSSEN PHARMACEUTICA NV (20)· patent assignee history

2006–2015Patents assigned to REITZ ALLEN B (17)· patent assignee history

2013–2015Patents assigned to SMITH-SWINTOSKY VIRGINIA L (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ORTHO MCNEIL PHARM INC	21	1999–2010
JANSSEN PHARMACEUTICA NV	20	2006–2015
REITZ ALLEN Bself	17	2006–2015
MCNEILAB INC	7	1988–1996
SMITH-SWINTOSKY VIRGINIA L	7	2013–2015

Locations

Location	Patents	Span
Lansdale, Pennsylvania, US	78	1994–2021
North Wales, Pennsylvania, US	1	1988